Topic

regulation

4 articles on regulation in longevity medicine. View all news →

FDA Compounding and FDA Q&A

Who Regulates US Longevity Clinics in 2026? FDA, State Boards, Compounding, and Off-Label Care

US longevity clinics are not outside regulation, but oversight is split. This map explains FDA product rules, state professional oversight, compounding, off-label care, and what patients can verify.

ArentFox Schiff press release

Longevity Clinic Legal Readiness in 2026: Six Questions Behind ArentFox Schiff's New Practice

ArentFox Schiff's longevity practice announcement is a useful prompt for an operator checklist covering licensing, claims, products, data, contracts, and cross-border care.

European Medicines Agency ATMP overview

EU ATMP Rules for Longevity Clinics in 2026: Authorisation, Hospital Exemption, and Red Flags

A clinic's use of the words stem cell or regenerative does not reveal its legal pathway. This guide explains EU ATMP classification, central authorisation, trials, the hospital exemption, and warning signs.

stem cells regulation EMA
Ultimate Longevity Center location directory

Ultimate Longevity Center in 2026: 16 Announced Locations, All Marked Coming Soon

The brand lists 16 planned centers across 10 US states, but every location is still marked Coming Soon. Here is what is public, what remains unverified, and what patients should ask before booking.